Biodesix Inc financial data

Symbol
BDSX on Nasdaq
Location
919 West Dillon Road, Louisville, CO
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 7, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 261 % +93.9%
Debt-to-equity 514 % -51%
Return On Equity -270 % +48.7%
Return On Assets -43.9 % +4.02%
Operating Margin -44.5 % +18.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 147M shares +1%
Common Stock, Shares, Outstanding 147M shares +0.99%
Entity Public Float 74M USD +102%
Common Stock, Value, Issued 146K USD +0.69%
Weighted Average Number of Shares Outstanding, Basic 147M shares +15.3%
Weighted Average Number of Shares Outstanding, Diluted 147M shares +15.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 76.6M USD +25.7%
Research and Development Expense 11.1M USD +31.8%
Selling and Marketing Expense 1.98M USD -13.4%
Operating Income (Loss) -34.1M USD -2.39%
Nonoperating Income (Expense) -6.98M USD +37.7%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -41.1M USD +7.71%
Earnings Per Share, Basic 0 USD/shares +40%
Earnings Per Share, Diluted 0 USD/shares +40%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 20.7M USD -50.9%
Accounts Receivable, after Allowance for Credit Loss, Current 7.45M USD -26.4%
Other Assets, Current 4.27M USD -18.5%
Assets, Current 32.4M USD -43.7%
Property, Plant and Equipment, Net 26.1M USD -6.72%
Operating Lease, Right-of-Use Asset 2.11M USD +19.2%
Intangible Assets, Net (Excluding Goodwill) 4.87M USD -29.2%
Goodwill 15M USD 0%
Other Assets, Noncurrent 7.15M USD +9.01%
Assets 87.7M USD -24.3%
Accounts Payable, Current 2.97M USD +33.9%
Employee-related Liabilities, Current 6.54M USD +40.7%
Accrued Liabilities, Current 9.68M USD +16.3%
Contract with Customer, Liability, Current 617K USD +38%
Liabilities, Current 15.2M USD -13.6%
Operating Lease, Liability, Noncurrent 24.1M USD -5.37%
Other Liabilities, Noncurrent 549K USD -26.2%
Liabilities 86.6M USD +8.82%
Retained Earnings (Accumulated Deficit) -485M USD -9.25%
Stockholders' Equity Attributable to Parent 1.14M USD -96.9%
Liabilities and Equity 87.7M USD -24.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -8.6M USD +43.8%
Net Cash Provided by (Used in) Financing Activities 97K USD -87.7%
Net Cash Provided by (Used in) Investing Activities -137K USD +49.8%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 147M shares +0.99%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -8.64M USD +41.6%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 20.8M USD -50.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.38M USD -6.51%
Deferred Tax Assets, Valuation Allowance 99M USD +6.42%
Deferred Tax Assets, Gross 101M USD +6.21%
Operating Lease, Liability 25.3M USD -1.69%
Depreciation 900K USD 0%
Payments to Acquire Property, Plant, and Equipment 74K USD -68.4%
Lessee, Operating Lease, Liability, to be Paid 42.4M USD -7.33%
Property, Plant and Equipment, Gross 37M USD +4.74%
Operating Lease, Liability, Current 1.23M USD +311%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.07M USD -2.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.18M USD +7.06%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 17.1M USD -14.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.16M USD +2.39%
Deferred Tax Assets, Operating Loss Carryforwards 78.4M USD +7.77%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 48K USD -95.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four 4.25M USD +2.41%
Additional Paid in Capital 486M USD +1.24%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 1.51M USD -24%
Deferred Tax Assets, Net of Valuation Allowance 1.93M USD -3.3%
Share-based Payment Arrangement, Expense 4.79M USD -18.7%
Interest Expense 1.9M USD -1.91%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%